NASDAQ:MAAC

Montes Archimedes Acquisition Competitors

$9.81
-0.02 (-0.20 %)
(As of 04/20/2021 10:16 AM ET)
Add
Compare
Today's Range
$9.81
Now: $9.81
$9.81
50-Day Range
$9.65
MA: $9.86
$10.20
52-Week Range
$9.61
Now: $9.81
$10.87
Volume17 shs
Average Volume210,049 shs
Market Capitalization$515.73 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Montes Archimedes Acquisition (NASDAQ:MAAC) Vs. AJAX, AJAX, PNTM, BTWN, CMLF, and BOAC

Should you be buying MAAC stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to Montes Archimedes Acquisition, including Ajax I (AJAX), Ajax I (AJAX), Pontem (PNTM), Bridgetown (BTWN), CM Life Sciences (CMLF), and Bluescape Opportunities Acquisition (BOAC).

Ajax I (NYSE:AJAX) and Montes Archimedes Acquisition (NASDAQ:MAAC) are both small-cap unclassified companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership.

Valuation & Earnings

This table compares Ajax I and Montes Archimedes Acquisition's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
Montes Archimedes AcquisitionN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations and price targets for Ajax I and Montes Archimedes Acquisition, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
Montes Archimedes Acquisition0000N/A

Profitability

This table compares Ajax I and Montes Archimedes Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
Montes Archimedes AcquisitionN/AN/AN/A

Ajax I (NYSE:AJAX) and Montes Archimedes Acquisition (NASDAQ:MAAC) are both small-cap unclassified companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Analyst Ratings

This is a breakdown of current ratings for Ajax I and Montes Archimedes Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
Montes Archimedes Acquisition0000N/A

Profitability

This table compares Ajax I and Montes Archimedes Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
Montes Archimedes AcquisitionN/AN/AN/A

Valuation and Earnings

This table compares Ajax I and Montes Archimedes Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
Montes Archimedes AcquisitionN/AN/AN/AN/AN/A

Pontem (NYSE:PNTM) and Montes Archimedes Acquisition (NASDAQ:MAAC) are both small-cap financial services companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Profitability

This table compares Pontem and Montes Archimedes Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PontemN/AN/AN/A
Montes Archimedes AcquisitionN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations for Pontem and Montes Archimedes Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pontem0000N/A
Montes Archimedes Acquisition0000N/A

Earnings and Valuation

This table compares Pontem and Montes Archimedes Acquisition's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PontemN/AN/AN/AN/AN/A
Montes Archimedes AcquisitionN/AN/AN/AN/AN/A

Montes Archimedes Acquisition (NASDAQ:MAAC) and Bridgetown (NASDAQ:BTWN) are both small-cap unclassified companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings.

Earnings and Valuation

This table compares Montes Archimedes Acquisition and Bridgetown's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Montes Archimedes AcquisitionN/AN/AN/AN/AN/A
BridgetownN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Montes Archimedes Acquisition and Bridgetown, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Montes Archimedes Acquisition0000N/A
Bridgetown0000N/A

Profitability

This table compares Montes Archimedes Acquisition and Bridgetown's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Montes Archimedes AcquisitionN/AN/AN/A
BridgetownN/AN/AN/A

Montes Archimedes Acquisition (NASDAQ:MAAC) and CM Life Sciences (NASDAQ:CMLF) are both small-cap unclassified companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings for Montes Archimedes Acquisition and CM Life Sciences, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Montes Archimedes Acquisition0000N/A
CM Life Sciences0000N/A

Earnings and Valuation

This table compares Montes Archimedes Acquisition and CM Life Sciences' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Montes Archimedes AcquisitionN/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

Profitability

This table compares Montes Archimedes Acquisition and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Montes Archimedes AcquisitionN/AN/AN/A
CM Life SciencesN/AN/AN/A

Montes Archimedes Acquisition (NASDAQ:MAAC) and Bluescape Opportunities Acquisition (NYSE:BOAC) are both small-cap unclassified companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership and risk.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Montes Archimedes Acquisition and Bluescape Opportunities Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Montes Archimedes Acquisition0000N/A
Bluescape Opportunities Acquisition0000N/A

Earnings & Valuation

This table compares Montes Archimedes Acquisition and Bluescape Opportunities Acquisition's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Montes Archimedes AcquisitionN/AN/AN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares Montes Archimedes Acquisition and Bluescape Opportunities Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Montes Archimedes AcquisitionN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/A


Montes Archimedes Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ajax I logo
AJAX
Ajax I
0.0$10.00-0.3%$897.11 millionN/A0.00Increase in Short Interest
Ajax I logo
AJAX
Ajax I
0.0$10.00-0.3%$897.11 millionN/A0.00Increase in Short Interest
PNTM
Pontem
0.0$9.78-0.2%$845.25 millionN/A0.00
BTWN
Bridgetown
0.0$10.31-2.7%$787.62 millionN/A0.00
CMLF
CM Life Sciences
0.0$13.60-1.7%$765.41 millionN/A0.00News Coverage
BOAC
Bluescape Opportunities Acquisition
0.0$9.93-0.0%$754.06 millionN/A0.00
VYGG
Vy Global Growth
0.0$10.15-0.6%$733.84 millionN/A0.00
BOWX
BowX Acquisition
0.0$11.57-2.1%$713.03 millionN/A0.00
LCY
Landcadia Holdings III
1.7$10.48-0.3%$676.58 millionN/A0.00
TPGY
TPG Pace Beneficial Finance
0.3$14.77-4.5%$675.06 millionN/A0.00
HZON
Horizon Acquisition Co. II
0.0$10.05-0.5%$669.57 millionN/A0.00
ACIC
Atlas Crest Investment
0.0$9.91-0.4%$616.88 millionN/A0.00
MIT
Mason Industrial Technology
0.0$9.75-0.8%$614.38 millionN/A0.00
HAAC
Health Assurance Acquisition
0.0$10.21-2.8%$581.44 millionN/A0.00
VSPR
Vesper Healthcare Acquisition
1.7$9.97-0.1%$572.70 millionN/A0.00Analyst Report
Unusual Options Activity
News Coverage
KVSC
Khosla Ventures Acquisition Co. III
0.0$10.06-0.7%$570.32 millionN/A0.00
VAQC
Vector Acquisition Corp II
0.0$9.89-0.6%$567.19 millionN/A0.00Quiet Period Expiration
News Coverage
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$9.95-0.3%$561.38 millionN/A0.00
MOTV
Motive Capital
0.0$9.84-0.8%$513.36 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.0$9.87-0.2%$510.77 millionN/A0.00
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.89-0.3%$506.50 millionN/A0.00
DGNU
ArcLight Clean Transition Corp. II Unit
0.0$10.02-0.9%$505.50 millionN/A0.00
EPHY
Epiphany Technology Acquisition
0.0$9.80-0.5%$503.45 millionN/A0.00
Supernova Partners Acquisition logo
SPNV
Supernova Partners Acquisition
0.0$9.86-0.9%$500.61 millionN/A0.00Increase in Short Interest
News Coverage
GMII
Gores Metropoulos II
0.0$9.99-0.1%$499.50 millionN/A0.00
MUDS
Mudrick Capital Acquisition Co. II
0.0$12.04-4.7%$498.49 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$9.86-0.9%$496.09 millionN/A0.00
DCRN
Decarbonization Plus Acquisition Co. II
0.0$9.78-0.6%$495.08 millionN/A0.00
AGCB
Altimeter Growth Corp. 2
0.0$10.85-0.4%$486.45 millionN/A0.00Gap Up
KVSB
Khosla Ventures Acquisition Co. II
0.0$10.19-0.3%$471.14 millionN/A0.00
NGAC
NextGen Acquisition
0.0$9.88-0.0%$463.13 millionN/A0.00
HIGA
H.I.G. Acquisition
0.0$9.91-0.2%$451.75 millionN/A0.00
SPFR
Jaws Spitfire Acquisition
0.0$10.11-0.9%$439.88 millionN/A0.00
LUXA
Lux Health Tech Acquisition
0.0$10.08-1.1%$439.44 millionN/A0.00
ACII
Atlas Crest Investment Corp. II
0.0$10.07-0.2%$433.41 millionN/A0.00
RMGB
RMG Acquisition Co. II
0.0$9.92-0.2%$428.66 millionN/A0.00
CAP
Capitol Investment Corp. V
0.0$9.90-0.1%$426.51 millionN/A0.00
GFX
Golden Falcon Acquisition
0.0$9.88-0.2%$425.21 millionN/A0.00
KURI
Alkuri Global Acquisition
0.0$9.80-0.5%$424.78 millionN/A0.00
DHHC
DiamondHead
0.0$9.85-0.3%$424.78 millionN/A0.00
CBAH
CBRE Acquisition
0.0$9.94-0.1%$419.67 millionN/A0.00
FSRV
FinServ Acquisition
0.0$12.60-4.2%$419.04 millionN/A0.00
GHVI
Gores Holdings VI
0.0$11.80-2.6%$417.80 millionN/A0.00
PCPC
Periphas Capital Partnering
0.0$24.59-1.3%$413.26 millionN/A0.00High Trading Volume
News Coverage
FTCV
Fintech Acquisition Corp. V
0.3$11.49-1.1%$397.25 millionN/A0.00
SWBK
Switchback II
0.0$9.97-0.6%$396.50 millionN/A0.00
NSTB
Northern Star Investment Corp. II
0.0$9.90-0.0%$396 millionN/A0.00
HMCO
HumanCo Acquisition
0.0$9.88-0.8%$382.84 millionN/A0.00
RAAC
Revolution Acceleration Acquisition
0.0$9.95-0.1%$381.80 millionN/A0.00
TSIA
TS Innovation Acquisitions
0.0$10.07-0.7%$380.25 millionN/A0.00Increase in Short Interest
News Coverage
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.